Position history for BlackRock, Inc.'s holdings in LEXEO THERAPEUTICS INC
BlackRock, Inc. holds 5.1M shares of LXEO (LEXEO THERAPEUTICS INC), worth $29.3M as of 2026-Q1. The position was increased (+4.1% shares). LXEO represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$29.3M
Current Shares
5.1M
Total Value Change
+$17.3M
Total Shares Change
+3.3M
Other major holders of LXEO: JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C., CITADEL ADVISORS LLC
Increased |
| 5.1M |
+4.1% |
| $29.3M |
| 0.0% |
| $7.07 |
30 |
| 2025-Q4 | Increased | 4.9M | +126.0% | $48.7M | 0.0% | $9.74 | 47 |
| 2025-Q3 | Increased | 2.2M | +18.8% | $14.4M | 0.0% | $6.66 | 33 |
| 2025-Q2 | Decreased | 1.8M | -0.8% | $7.3M | 0.0% | $4.12 | 0 |
| 2025-Q1 | Increased | 1.8M | +1.1% | $6.4M | 0.0% | $4.10 | 27 |
| 2024-Q4 | New | 1.8M | - | $12M | 0.0% | $6.54 | 39 |